Page 5 of lupin

Dronedarone Tablets (RLD Multaq) had estimated annual sales of USD 510 million in the U.S. (IQVIA MAT December 2023).

Rivaroxaban Tablets USP (RLD Xarelto) had estimated annual sales of USD 8,249 million in the U.S. (IQVIA MAT November 2023).

Febuxostat Tablets (RLD Uloric) had estimated annual sales of USD 27 million in the U.S. (IQVIA MAT November 2023).

Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix Tablets, 0.5 mg and 1 mg, of…

This product will be manufactured at Lupin’s Pithampur facility in India.

These are the generic equivalents of Chantix tablets, 0.5 mg and 1 mg, of PF Prism CV.

The product is available in a single-strength fixed dose, with a recommended once-daily dosage.

Canagliflozin Tablets (RLD Invokana) had estimated annual sales of USD 561 million in the U.S. (IQVIA MAT September 2023).

Bromfenac Ophthalmic Solution (RLD Prolensa) had estimated annual sales of USD 185 million in the U.S. (IQVIA MAT September 2023).

Pitavastatin Tablets (RLD Livalo) had estimated annual sales of USD 298 million in the U.S. (IQVIA MAT September 2023).

This product will be manufactured at Lupin’s Pithampur facility in India.